CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Hydrophilic emulsion for the relief of haemorroidal symptomsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06944951
NCT06944951N/ACompleted
CompareCT.gov

Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device PROCTOeze® PLUS in the Relief of Haemorrhoidal Disease and Anal Irritation Symptoms

Biokosmes Srl·interventional·Posted Apr 25, 2025·Updated Feb 5, 2026

In Brief

A clinical study evaluating Hydrophilic emulsion for the relief of haemorroidal symptoms for Haemorrhoidal Disease. Completed, enrolled 50 participants across 1 site.

Detailed Summary

This trial aims to evaluate the overall performance and safety of the MD PROCTOeze® PLUS in relieving symptomatology of haemorrhoidal disease and anal irritation in adult patients affected by Grade I-II (Goligher classification) haemorrhoids as assessed by the patient and the Investigator at the end of the treatment period.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHaemorrhoidal Disease
CountriesRomania
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedApr 25, 2025
Enrollment StartNov 5, 2024
Primary CompletionJan 17, 2025
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 1.2 years ago

Interventions

Hydrophilic emulsion for the relief of haemorroidal symptomsdevice

Administration for 2 weeks of PROCTOeze® PLUS - a soft and light hydrophilic emulsion able to provide symptomatic relief of haemorrhoids and anal irritation.